• Free Express Shipping on Orders $200+
  • Get Premium-Grade Peptides and Save When You Buy in Bundles
  • Made in the USA

Safety data sheet. GHS / OSHA HCS 2012 format, 16 sections. Issued by Epic Peptides Lab for the catalogue items listed in Section 1.

Epic Peptides Lab

Safety data sheet · capsules

Epic Peptides Lab · USA

Document number
PL-SDS-003
Revision
1.0 · 2026-10-03

5-Amino-1MQ

capsules

WARNING

1Identification

Product Identifier
5-Amino-1MQ
Document Number
PL-SDS-003
Catalogue Items Covered
  • Id
    5058
    Name
    5-Amino-1MQ 50mg (60 Capsules)
    Sku
    PL-5A1MQ-50MG-CAP
Recommended Use
Laboratory research use by trained personnel.
Restrictions On Use
Not for human or veterinary use.
Supplier / Distributor
Epic Peptides Lab, USA
Telephone
+1 (787) 468-5291
Email
info@epicpeptideslab.com

2Hazard(s) identification

Classification
  • Skin corrosion/irritation — Category 2 — H315
  • Serious eye damage/eye irritation — Category 2A — H319
Label Elements
Pictograms
  • GHS07
Signal
Warning
Hazard statements
  • H315 Causes skin irritation.
  • H319 Causes serious eye irritation.
Precautionary statements
  • P264 Wash hands and any exposed skin thoroughly after handling.
  • P280 Wear protective gloves, protective clothing and eye protection.
  • P302+P352 IF ON SKIN: Wash with plenty of water.
  • P305+P351+P338 IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing.
  • P321 Specific treatment: see Section 4 of this safety data sheet.
  • P332+P313 If skin irritation occurs: Get medical advice/attention.
  • P337+P313 If eye irritation persists: Get medical advice/attention.
  • P362+P364 Take off contaminated clothing and wash it before reuse.
Signal Word
Warning
Other Hazards
No data available.

3Composition / information on ingredients

Description
Hard gelatin capsules containing the active substance blended with microcrystalline cellulose, packed in a sealed bottle.
Composition
  • Name
    5-Amino-1MQ
    Full
    5-Amino-1-methylquinolinium iodide (NNMT inhibitor); small molecule, not a peptide
    Cas
    42464-96-0
    Formula
    C10H11IN2
    Conc
    12% w/w of capsule contents (nominal)
    Qty
    50 mg per capsule
    Hazards
    • Acute toxicity, oral — Category 4 — H302
    • Skin corrosion/irritation — Category 2 — H315
    • Serious eye damage/eye irritation — Category 2A — H319
    • Specific target organ toxicity, single exposure (respiratory tract irritation) — Category 3 — H335
  • Name
    Microcrystalline cellulose
    Full
    Microcrystalline cellulose (capsule filler)
    Cas
    9004-34-6
    Formula
    (C6H10O5)n
    Conc
    balance of capsule contents
  • Name
    Gelatin
    Full
    Gelatin (capsule shell)
    Cas
    9000-70-8
    Conc
    capsule shell

4First-aid measures

First Aid Measures
Inhalation
Move the person to fresh air and keep comfortable for breathing. If breathing is difficult or symptoms persist, call a POISON CENTER or doctor.
Skin
Take off contaminated clothing. Wash the skin with plenty of soap and water. If irritation or a rash develops, get medical advice.
Eyes
Rinse cautiously with water for several minutes. Remove contact lenses if present and easy to do; continue rinsing. If eye irritation persists, get medical advice.
Ingestion
Rinse mouth. Do not induce vomiting. Call a POISON CENTER or doctor if you feel unwell.
Most Important Symptoms And Effects
skin redness or irritation; eye redness, watering and irritation.
Likely Routes Of Exposure
Ingestion; inhalation of dust and skin/eye contact if capsules are opened.

5Fire-fighting measures

Fire Fighting Information
Combustible organic solid; capsule contents may form combustible dust if dispersed in bulk.

6Accidental release measures

Spill And Clean Up Procedures
Collect intact capsules. Dampen any spilled powder with water, wipe up with absorbent material and place in a sealed container for disposal.

7Handling and storage

Safe Handling
Do not open or crush capsules unless required for an experiment; if capsule contents are handled as a powder, avoid generating dust and weigh inside a ventilated enclosure. Wash hands after handling.
Safe Storage
Store at room temperature (15–25 °C) in the tightly closed original container, dry and protected from light.
Storage Temperature
15–25 °C, dry, protected from light
Incompatible Materials
Strong oxidizing agents; strong acids/bases (generic for quaternary quinolinium iodides; iodide can be oxidized to iodine)

8Exposure controls / personal protection

Occupational Exposure Limits
  • Microcrystalline cellulose: OSHA PEL 15 mg/m³ (total dust), 5 mg/m³ (respirable fraction); ACGIH TLV 10 mg/m³ (as cellulose).
  • No occupational exposure limits have been established for the active ingredient(s).
Exposure Controls And PPE
No data available.

9Physical and chemical properties

Physical State
Solid
Appearance
Hard gelatin capsules containing a white to off-white powder
Properties
Odor
No data available
Ph
Not applicable (solid)
Melting
213-214 °C (ChemicalBook)
Boiling
No data available
Flash
Not applicable (non-flammable solid); combustible organic material
Vapour
Negligible (solid)
Density
No data available (bulk density of lyophilized cake is low)
Solubility
DMSO: 2 mg/mL, clear (Sigma-Aldrich); water-soluble quaternary salt per vendor literature (not quantified)
Logp
No data available
Decomp
No data available; peptides decompose above about 200 °C
Other
Storage class 11 (combustible solids), WGK 3 (Sigma-Aldrich); flash point not applicable; store at -20 °C; MW 286.11; the Sigma assay is >=98% (HPLC)

10Stability and reactivity

Stability And Reactivity
Reactivity
Stable under recommended storage conditions (-20 °C, dark, dry). No dangerous reactions known.
Incompatible
Strong oxidizing agents; strong acids/bases (generic for quaternary quinolinium iodides; iodide can be oxidized to iodine)
Decomposition
On combustion may form carbon oxides, nitrogen oxides and hydrogen iodide/iodine vapours
Conditions To Avoid
Light, moisture, heat; light-sensitive iodide salt (store dark, desiccated)
Conditions To Avoid
Light, moisture, heat; light-sensitive iodide salt (store dark, desiccated)
Incompatible Materials
No data available.

11Toxicological information

Toxicological Information
  • Acute toxicity, oral

    No LD50 published by the suppliers found; classified Acute Tox. 4 oral (H302) on the Sigma-type SDS mirrored by ChemicalBook

  • Acute toxicity, dermal

    No data available

  • Acute toxicity, inhalation

    No data available

  • Skin corrosion/irritation

    Skin irritation Category 2 (H315) per Sigma-type classification; no study data

  • Serious eye damage/irritation

    Eye irritation Category 2A (H319) per Sigma-type classification; no study data

  • Respiratory or skin sensitisation

    No data available

  • Germ cell mutagenicity

    No data available

  • Carcinogenicity

    No data available; not listed by IARC, NTP, OSHA

  • Reproductive toxicity

    No data available

  • STOT, single exposure

    Category 3, respiratory tract irritation (H335) per Sigma-type classification

  • STOT, repeated exposure

    No data available

  • Aspiration hazard

    No data available

Routes Of Exposure
Ingestion; inhalation of dust and skin/eye contact if capsules are opened.
Symptoms
skin redness or irritation; eye redness, watering and irritation.

12Ecological information

Ecological Information
No ecotoxicity data located. Sigma-Aldrich assigns WGK 3 (highly hazardous to water) by self-assessment, which is a default for data-poor substances rather than a measured result; do not let the product reach drains.

13Disposal considerations

Disposal Guidance
No data available.

14Transport information

Transport Classification
Note
Not regulated as a dangerous good for transport by road (DOT 49 CFR), air (IATA/ICAO) or sea (IMDG). Not a marine pollutant. Ship refrigerated or frozen as required by Section 7; the coolant (dry ice, UN 1845) is regulated when used.

15Regulatory information

Regulatory Information
Tsca
Not listed (research chemical)
Carcinogen Listings
Not listed by IARC, NTP, OSHA or California Prop 65
Dea
Not a controlled substance
Other
Not a WADA-prohibited substance. Not an approved drug anywhere; sold strictly for research.
Carcinogen Listings
No data available.

16Other information

Revision
October 3, 2026
Sources Consulted
  • Sigma-Aldrich
  • ChemicalBook
  • Spectrum Chemical
  • Sigachi Industries
  • Parchem
  • Fisher Scientific / Acros Organics
  • Electron Microscopy Sciences
Confidence
medium
Additional Information
  • Quaternary quinolinium iodide salt; permanently cationic. Not a peptide.
Back to SDS list
JOIN THE Epic Peptides Lab
Exclusive access for verified researchers only.

Enter your details to access our catalog, COA library,
and research compound database.

By submitting you agree to receive email communications from Epic Peptides Lab You can unsubscribe at any time. All products for in vitro research use only.

  • The Email Catalog
15% off any order

Restock alerts, new compounds and fresh lab results.
We’ll email your code straight away – 15% off, one-time use.

  • ≥99%
  • COA every batch
  • Ships from USA

Research updates only. Unsubscribe any time.